Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1987 1
1989 2
2011 1
2022 1
2025 1
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7 results

Results by year

Filters applied: Meta-Analysis, Randomized Controlled Trial. Clear all
Page 1
A Randomized Controlled Pilot Study Evaluating the Safety and Efficacy of Nifuroxazide in Patients with Ulcerative Colitis.
AlRasheed HA, Abdallah MS, El-Khateeb E, Kamal M, Alrubia S, Alsegiani AS, Ahmed TI, Bahaa MM. AlRasheed HA, et al. Drug Des Devel Ther. 2025 Jun 30;19:5539-5552. doi: 10.2147/DDDT.S522755. eCollection 2025. Drug Des Devel Ther. 2025. PMID: 40620467 Free PMC article. Clinical Trial.
BACKGROUND: The therapeutic potential of nifuroxazide in colitis has been explored in several experimental studies of ulcerative colitis (UC). ...The placebo group received a placebo alongside mesalamine (1 g three times daily [t.i.d.]) for six months. The nifuroxazide …
BACKGROUND: The therapeutic potential of nifuroxazide in colitis has been explored in several experimental studies of ulcerative coli …
[Effects of nifuroxazide on fecal flora in healthy subjects].
Buisson Y, Larribaud J. Buisson Y, et al. Therapie. 1989 Mar-Apr;44(2):123-6. Therapie. 1989. PMID: 2756516 Clinical Trial. French.
Effect of nifuroxazide on fecal flora was studied in 12 healthy volunteers receiving, in hazardous order and double-blind procedure, three six-days courses of treatment separated by eight-days spaces of time: the conventional dosage of 400 mg twice a day, a dosage of 1200 …
Effect of nifuroxazide on fecal flora was studied in 12 healthy volunteers receiving, in hazardous order and double-blind procedure, …
[Double-blind controlled study of the efficacy of nifuroxazide versus placebo in the treatment of acute diarrhea in adults].
Bourée P, Chaput JC, Krainik F, Michel H, Trépo C. Bourée P, et al. Gastroenterol Clin Biol. 1989 May;13(5):469-72. Gastroenterol Clin Biol. 1989. PMID: 2666238 Clinical Trial. French.
In a double-blind, controlled randomized trial, 88 adult patients with acute diarrhea (more than three watery stools per day) received either 400 mg of nifuroxazide twice daily or placebo for 5 days. The mean duration of diarrhea in the nifuroxazide group was 2.09 d …
In a double-blind, controlled randomized trial, 88 adult patients with acute diarrhea (more than three watery stools per day) received eithe …
Comparative physiological disposition of two nitrofuran anti-microbial agents.
Labaune JP, Moreau JP, Byrne R. Labaune JP, et al. Biopharm Drug Dispos. 1986 Sep-Oct;7(5):431-41. doi: 10.1002/bdd.2510070504. Biopharm Drug Dispos. 1986. PMID: 3779034 Clinical Trial.
Upon administration of a single oral dose (600 mg) of nifurzide or nifuroxazide, no unchanged parent drug was detected in human blood or urine. In rats given 14C-nifurzide and 14C-nifuroxazide at a dose of 10 mg kg-1, 5 per cent and 17 per cent of the dose of nifurz …
Upon administration of a single oral dose (600 mg) of nifurzide or nifuroxazide, no unchanged parent drug was detected in human blood …
[The effectiveness of a probiotic containing Bifidobacterium longum BB-46 and Enterococcus faecium ENCfa-68 in the treatment of post-infectious irritable bowel syndrome. Prospective randomized comparative study].
Yakovenko EP, Strokova TV, Ivanov AN, Iakovenko AV, Gioeva IZ, Aldiyarova MA. Yakovenko EP, et al. Ter Arkh. 2022 Feb 15;94(2):180-187. doi: 10.26442/00403660.2022.02.201368. Ter Arkh. 2022. PMID: 36286741 Clinical Trial. Russian.
The patients of the main group received an antispasmodic drug (mebeverin 200 mg 2 times a day or trimebutin 200 mg 3 times a day for 4 weeks), an antibiotic (rifaximin 400 mg 3 times a day or nifuroxazide 400 mg 2 once a day for 1 week), a drug that normalizes the consiste …
The patients of the main group received an antispasmodic drug (mebeverin 200 mg 2 times a day or trimebutin 200 mg 3 times a day for 4 weeks …